BIOMAT Database Logo BIOMAT Database Logo

Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome. 1985

O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann

Titers of circulating interferon (IFN) and the activity of 2'-5' oligoadenylate (2-5A) synthetase, an enzyme specifically induced by IFN, were measured in 28 homosexual men with acquired immunodeficiency syndrome (AIDS) who received one- to six-month courses of antineoplastic therapy with IFN-alpha and in homosexual and heterosexual controls. Fifteen of the patients and two of seven healthy homosexual men had high endogenous levels of 2-5A synthetase. IFN therapy induced further increases in this enzyme in only 10 of the 28 patients with AIDS. Furthermore, peripheral blood cells from all but one of the patients with AIDS and homosexual controls tested were markedly deficient in their ability to respond to IFN in vitro, as measured by increased levels of 2-5A synthetase. We did not find a statistical correlation between cytomegalovirus viremia and pretherapy endogenous circulating IFN, nor any apparent correlation between disseminated infection with cytomegalovirus and either basal levels of 2-5A synthetase or changes in enzyme level during therapy. Pretherapy circulating IFN was significantly correlated with progressive Kaposi's sarcoma during therapy, but rises in levels of 2-5A synthetase were not sufficient to predict a good clinical response.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006716 Homosexuality The sexual attraction or relationship between members of the same SEX. Homosexuality, Ego-Dystonic,Ego-Dystonic Homosexuality,Homosexuality, Ego Dystonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Interferon-alpha therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome.
January 1991, International journal of immunopharmacology,
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
[Acquired immunodeficiency and Kaposi's sarcoma in homosexual men].
April 1982, Nederlands tijdschrift voor geneeskunde,
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome.
May 1984, Annals of internal medicine,
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome.
September 1985, The Journal of infectious diseases,
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Oral Kaposi's sarcoma associated with acquired immunodeficiency syndrome among homosexual males.
August 1983, Journal of the American Dental Association (1939),
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Human interferon-alpha production in homosexual men with the acquired immune deficiency syndrome.
July 1984, The Journal of infectious diseases,
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
January 1985, Journal of interferon research,
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Disease manifestation among homosexual men with acquired immunodeficiency syndrome: a possible role of nitrites in Kaposi's sarcoma.
January 1985, Sexually transmitted diseases,
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
February 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy,
O T Preble, and A H Rook, and R Steis, and R H Silverman, and D Krause, and G V Quinnan, and H Masur, and J Jacob, and D Longo, and E P Gelmann
Successful treatment of Kaposi's sarcoma with interferon-alpha in a patient with acquired immunodeficiency syndrome.
February 1993, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
Copied contents to your clipboard!